Gestational Surrogacy Age Limits and Genetic Risks Explained

Gestational surrogacy enables intended parents to use their biological materials, but maternal age significantly impacts mitochondrial DNA (mtDNA) risk. The American Society for Reproductive Medicine sets surrogate age limits at 21-45 years due to emotional maturity concerns. Mitochondrial disorders, inherited solely from mothers, can cause severe health issues, but three-parent IVF technology offers a solution by replacing defective mtDNA. A 2016 case in Mexico demonstrated the success of this method.

---

Key Takeaways

Age Limits for Surrogate Mothers: 21-45 Years Explained

Surrogates must be at least 21 years old to ensure emotional readiness for relinquishing a child. The upper limit of 45 years is set to mitigate risks of genetic disorders linked to maternal aging.

Mitochondrial DNA Inheritance and Genetic Risks in Surrogacy

Mitochondrial DNA (mtDNA) is inherited exclusively from mothers. Defective mtDNA can cause severe diseases in organs like the heart and brain, with older mothers facing higher transmission risks due to mitochondrial dysfunction.

Three-Parent IVF: A Genetic Solution for Mitochondrial Diseases

Three-parent IVF replaces faulty maternal mtDNA with donor mitochondria, preventing genetic disease transmission. This technology allows older mothers to conceive healthy children without oocyte donation, preserving genetic links.

Whole Oocyte Donation: Trade-Offs for Genetic Risk Mitigation

Donating unaffected oocytes eliminates mtDNA risks but removes the child’s genetic tie to the intended mother. This approach is less accepted due to emotional and cultural preferences for biological connections.

First Three-Parent Baby Case in Mexico (2016) Validates Technology

A successful 2016 case in Mexico produced a healthy ‘three-parent’ baby using mitochondrial replacement therapy. This breakthrough demonstrates the feasibility of preventing genetic disease transmission in high-risk families.

---

Source: Read full article